Search

Search Constraints

You searched for: Author/Creator Franceschini, Luca

Search Results

1. Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life. (4th March 2021)

3. Comparison between biosimilar filgrastim vs other granulocyte‐colony stimulating factor formulations (originator filgrastim, peg‐filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network. (5th November 2014)

4. Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group. Issue 1 (15th January 2022)

5. Dasatinib first-line: Multicentric Italian experience outside clinical trials. (January 2016)

6. Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation. (4th April 2019)

7. Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations. (23rd April 2019)

8. Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia. Issue 5 (24th February 2018)

9. Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence‐Jones in nephelometry?. (18th December 2015)

10. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging. (June 2015)